BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26212315)

  • 1. Dramatic effect of levetiracetam in early-onset epileptic encephalopathy due to STXBP1 mutation.
    Dilena R; Striano P; Traverso M; Viri M; Cristofori G; Tadini L; Barbieri S; Romeo A; Zara F
    Brain Dev; 2016 Jan; 38(1):128-31. PubMed ID: 26212315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic benefits of ACTH and levetiracetam in STXBP1 encephalopathy with a de novo mutation: A case report and literature review.
    Liu S; Wang L; Cai XT; Zhou H; Yu D; Wang Z
    Medicine (Baltimore); 2018 May; 97(18):e0663. PubMed ID: 29718889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations.
    Milh M; Villeneuve N; Chouchane M; Kaminska A; Laroche C; Barthez MA; Gitiaux C; Bartoli C; Borges-Correia A; Cacciagli P; Mignon-Ravix C; Cuberos H; Chabrol B; Villard L
    Epilepsia; 2011 Oct; 52(10):1828-34. PubMed ID: 21770924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and genetic characteristics of children with STXBP1 encephalopathy].
    Cao JJ; Ji XN; Mao YY; Zhang PP; Liu WT; Zhang HZ; Ding N; Chen Q
    Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):493-498. PubMed ID: 32521962
    [No Abstract]   [Full Text] [Related]  

  • 5. Protein instability, haploinsufficiency, and cortical hyper-excitability underlie STXBP1 encephalopathy.
    Kovacevic J; Maroteaux G; Schut D; Loos M; Dubey M; Pitsch J; Remmelink E; Koopmans B; Crowley J; Cornelisse LN; Sullivan PF; Schoch S; Toonen RF; Stiedl O; Verhage M
    Brain; 2018 May; 141(5):1350-1374. PubMed ID: 29538625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epileptic patients with de novo STXBP1 mutations: Key clinical features based on 24 cases.
    Di Meglio C; Lesca G; Villeneuve N; Lacoste C; Abidi A; Cacciagli P; Altuzarra C; Roubertie A; Afenjar A; Renaldo-Robin F; Isidor B; Gautier A; Husson M; Cances C; Metreau J; Laroche C; Chouchane M; Ville D; Marignier S; Rougeot C; Lebrun M; de Saint Martin A; Perez A; Riquet A; Badens C; Missirian C; Philip N; Chabrol B; Villard L; Milh M
    Epilepsia; 2015 Dec; 56(12):1931-40. PubMed ID: 26514728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of levetiracetam in STXBP1 encephalopathy with different phenotypic and genetic spectra.
    Wang QH; Cao JJ; Wang YY; Zhang MN; Liu LY; Wang J; Lu Q; He W; Shen YW; Chen HM; Luo XM; Chen Q; Zou LP
    Seizure; 2022 Feb; 95():64-74. PubMed ID: 35007884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A de novo nonsense mutation of STXBP1 causes early-onset epileptic encephalopathy.
    Suo G; Cao X; Zheng Y; Li H; Zhang Q; Tang J; Wu Y
    Epilepsy Behav; 2021 Oct; 123():108245. PubMed ID: 34390894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in STXBP1 gene in a child with epileptic encephalopathy and an atypical electroclinical pattern.
    Romaniello R; Zucca C; Tenderini E; Arrigoni F; Ragona F; Zorzi G; Bassi MT; Borgatti R
    J Child Neurol; 2014 Feb; 29(2):249-53. PubMed ID: 24170257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment with levetiracetam in a case of Ohtahara syndrome caused by STXBP1 mutation].
    Yamashita S; Chiyonobu T; Yoshida M; Moroto M; Morita T; Morioka S; Kato M; Saitsu H; Morimoto M; Hosoi H
    No To Hattatsu; 2013 Jan; 45(1):64-6. PubMed ID: 23593750
    [No Abstract]   [Full Text] [Related]  

  • 11. De novo mutations of STXBP1 in Chinese children with early onset epileptic encephalopathy.
    Li T; Cheng M; Wang J; Hong S; Li M; Liao S; Xie L; Jiang L
    Genes Brain Behav; 2018 Nov; 17(8):e12492. PubMed ID: 29896790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STXBP1-related encephalopathy presenting as infantile spasms and generalized tremor in three patients.
    Mignot C; Moutard ML; Trouillard O; Gourfinkel-An I; Jacquette A; Arveiler B; Morice-Picard F; Lacombe D; Chiron C; Ville D; Charles P; LeGuern E; Depienne C; Héron D
    Epilepsia; 2011 Oct; 52(10):1820-7. PubMed ID: 21762454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intellectual disability without epilepsy associated with STXBP1 disruption.
    Hamdan FF; Gauthier J; Dobrzeniecka S; Lortie A; Mottron L; Vanasse M; D'Anjou G; Lacaille JC; Rouleau GA; Michaud JL
    Eur J Hum Genet; 2011 May; 19(5):607-9. PubMed ID: 21364700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ataxia, tremor, intellectual disability: a case of STXBP1 encephalopathy with a new mutation.
    Değerliyurt A; Kesen GG; Ceylaner S
    Turk J Pediatr; 2019; 61(5):757-759. PubMed ID: 32105008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations.
    Deprez L; Weckhuysen S; Holmgren P; Suls A; Van Dyck T; Goossens D; Del-Favero J; Jansen A; Verhaert K; Lagae L; Jordanova A; Van Coster R; Yendle S; Berkovic SF; Scheffer I; Ceulemans B; De Jonghe P
    Neurology; 2010 Sep; 75(13):1159-65. PubMed ID: 20876469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel STXBP1 mutation causes focal seizures with neonatal onset.
    Vatta M; Tennison MB; Aylsworth AS; Turcott CM; Guerra MP; Eng CM; Yang Y
    J Child Neurol; 2012 Jun; 27(6):811-4. PubMed ID: 22596016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011412. PubMed ID: 29243813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early epileptic encephalopathies associated with STXBP1 mutations: Could we better delineate the phenotype?
    Barcia G; Chemaly N; Gobin S; Milh M; Van Bogaert P; Barnerias C; Kaminska A; Dulac O; Desguerre I; Cormier V; Boddaert N; Nabbout R
    Eur J Med Genet; 2014 Jan; 57(1):15-20. PubMed ID: 24189369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss-of-function mutations of STXBP1 in patients with epileptic encephalopathy.
    Yamamoto T; Shimojima K; Yano T; Ueda Y; Takayama R; Ikeda H; Imai K
    Brain Dev; 2016 Mar; 38(3):280-4. PubMed ID: 26384463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.